Cargando…

Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling

Detalles Bibliográficos
Autores principales: Yang, Wen, Zheng, Zhikun, Yi, Pengfei, Wang, Shi, Zhang, Ning, Ming, Jie, Tan, Jie, Guo, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430396/
https://www.ncbi.nlm.nih.gov/pubmed/34513720
http://dx.doi.org/10.3389/fonc.2021.759471
_version_ 1783750698973790208
author Yang, Wen
Zheng, Zhikun
Yi, Pengfei
Wang, Shi
Zhang, Ning
Ming, Jie
Tan, Jie
Guo, Hui
author_facet Yang, Wen
Zheng, Zhikun
Yi, Pengfei
Wang, Shi
Zhang, Ning
Ming, Jie
Tan, Jie
Guo, Hui
author_sort Yang, Wen
collection PubMed
description
format Online
Article
Text
id pubmed-8430396
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84303962021-09-11 Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui Front Oncol Oncology Frontiers Media S.A. 2021-08-27 /pmc/articles/PMC8430396/ /pubmed/34513720 http://dx.doi.org/10.3389/fonc.2021.759471 Text en Copyright © 2021 Yang, Zheng, Yi, Wang, Zhang, Ming, Tan and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Wen
Zheng, Zhikun
Yi, Pengfei
Wang, Shi
Zhang, Ning
Ming, Jie
Tan, Jie
Guo, Hui
Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title_full Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title_fullStr Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title_full_unstemmed Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title_short Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
title_sort corrigendum: lncrna nbr2 inhibits the malignancy of thyroid cancer, associated with enhancing the ampk signaling
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430396/
https://www.ncbi.nlm.nih.gov/pubmed/34513720
http://dx.doi.org/10.3389/fonc.2021.759471
work_keys_str_mv AT yangwen corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT zhengzhikun corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT yipengfei corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT wangshi corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT zhangning corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT mingjie corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT tanjie corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling
AT guohui corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling